Table 4.
Factor | P | HR (95% CI) |
---|---|---|
Treatment modality (CCRT vs chemotherapy) | 0.013 | 0.631 (0.438–0.907) |
Number of metastases organs (Solitary vs Multiple metastasis) | 0.037 | 0.668 (0.457–0.976) |
T-Stage (T1 + 2 vs T3 + 4) | 0.113 | 0.679 (0.421–1.096) |
Chemotherapy regimens (PTX + DDP vs 5-Fu + DDP) | 0.089 | 0.732 (0.511–1.049) |
Abbreviations: CCRT concurrent chemoradiotherapy, HR hazard ratio, CI confidence interval, OS overall survival